First Regenerative Cell Breast Augmentation Surgery Performed Through Stem Cell Assurance Physician Network

BOCA RATON, Fla., Jan. 20 /PRNewswire-FirstCall/ -- Stem Cell Assurance, Inc. (Pink Sheets: SCLZ) announced today that Arthur Handal, MD., F.A.C.S. has performed the first regenerative cell breast augmentation through its nationwide physician network.  The procedure was performed at Handal Plastic Surgery in Boca Raton, Florida in the practice's onsite accredited ambulatory surgical facility.  

The patient treated by Dr. Handal underwent regenerative cell breast augmentation on Monday with the goal of an approximate one cup size increase in each breast.  Fat was taken from her hips and thighs by tumescent liposuction and processed to extract naturally-occurring regenerative cells.  Commenting after the surgery, Dr. Handal stated, "Today is a defining moment in breast augmentation surgery.  The offering of this pioneering procedure through a collaborative national physician network is an important milestone that marks major improvement on current technology and the way in which it is delivered to the patient."

By using the Stem Cell Assurance method of breast augmentation, Dr. Handal was able to provide the patient with an augmentation that retains the natural look and feel of the breast.  This technique is currently the only way to perform a breast augmentation without introducing a foreign implant into the body.  The patient's own fat and regenerative cells are used to create a graft for reinsertion to the breast, resulting in no risk of the body rejecting it.  The Stem Cell Assurance technology offers improved outcomes in breast surgery. The fat volume retention rate is estimated to be 80% or more compared to the 30-50% survival rate of fat retention in previous fat grafting procedures.  This new procedure appears to offer a significant advantage with longer lasting results than traditional breast augmentation procedures.

Stem Cell Assurance believes that its method will provide surgeons with the ability to treat patients who may be apprehensive about implants but still want fuller-looking breasts.  Breast cancer patients will also now have another option for reconstruction after mastectomy.  "Our goal is to greatly improve the quality of breast surgery for patients, setting a new level of expectation for augmentation and fat grafting outcomes," said Kurt Wagner, MD, Chairman of the Company.  

The patient's clinical results will be monitored closely with scheduled follow-up by Dr. Handal.  More information on the surgery will soon be available on the Stem Cell Assurance website at www.stemcellassurance.com, including before-and-after photographs along with video footage of the procedure and technology.

About Stem Cell Assurance

Stem Cell Assurance, Inc. is the first company in the US to provide full-spectrum adult stem cell services to consumers through a national physician network.  The company offers genetic profiling services and consultation, adult stem cell research, and stem cell collection, processing, and cryogenic storage, as well as cosmetic and other infusion therapies.  The company is based in Boca Raton, Florida.  See www.stemcellassurance.com for more information.

About Dr. Handal

Dr. Handal is certified by the American Board of Plastic Surgery, and began his interest in plastic / cosmetic surgery at Chicago / UHS Medical School. During his general surgery residency at State University New York, he focused his attentions on plastic surgery, and gained early acceptance into the State University of New York / Kings County Medical Center. On completion of his residency, he continued his surgical training with prestigious fellowships in hand surgery at Hartford Hospital in Connecticut and aesthetic surgery in association with the University of Miami.  Dr. Handal dedicates his practice to the field of aesthetic plastic surgery, is a published author, and attends the major plastic and aesthetic surgery meetings several times a year to bring the latest techniques and innovations to his practice.

SOURCE Stem Cell Assurance, Inc.